ABSTRACT
Arterial hypercapnia reduces renal perfusion. Beetroot juice (BRJ) increases nitric oxide bioavailability and may improve renal blood flow. We tested the hypothesis that acute consumption of BRJ attenuates both decreases in blood velocity and increases in vascular resistance in the renal and segmental arteries during acute hypercapnia. In fourteen healthy young adults, blood velocity and vascular resistance were measured with Doppler ultrasound in the renal and segmental arteries during five minutes of breathing a carbon dioxide gas mixture (CO2) before and three hours after consuming 500 mL of BRJ. There was no difference between pre- and post-BRJ consumption in the increase in the partial pressure of end-tidal CO2 during CO2 breathing (pre: +4 ± 1 mmHg; post: +4 ± 2 mmHg, p = 0.4281). Segmental artery blood velocity decreased during CO2 breathing in both pre- (by -1.8 ± 1.9 cm/s, p = 0.0193) and post-BRJ (by -2.1 ± 1.9 cm/s, p = 0.0079), but there were no differences between pre- and post-consumption (p = 0.7633). Segmental artery vascular resistance increased from room air baseline during CO2 at pre-BRJ consumption (by 0.4 ± 0.4 mmHg/cm/s, p = 0.0153) but not post-BRJ (p = 0.1336), with no differences between pre- and post-consumption (p = 0.7407). These findings indicate that BRJ consumption does not attenuate reductions in renal perfusion during acute mild hypercapnia in healthy young adults.
Subject(s)
Beta vulgaris , Fruit and Vegetable Juices , Hemodynamics/drug effects , Hypercapnia/physiopathology , Kidney/blood supply , Plant Roots , Adult , Arterial Pressure , Blood Flow Velocity/drug effects , Carbon Dioxide , Drinking/physiology , Female , Healthy Volunteers , Humans , Male , Renal Artery/physiopathology , Respiration/drug effects , Tidal Volume/drug effects , Ultrasonography, Doppler , Vascular Resistance/drug effectsABSTRACT
The neural network that regulates breathing shows a significant sexual dimorphism. Ovarian hormones contribute to this distinction as, in rats, ovariectomy reduces the ventilatory response to CO2. Microglia are neuroimmune cells that are sensitive to neuroendocrine changes in their environment. When reacting to challenging conditions, these cells show changes in their morphology that reflect an augmented capacity for producing pro- and anti-inflammatory cytokines. Based on evidence suggesting that microglia contribute to sex-based differences in reflexive responses to hypercapnia, we hypothesized that ovariectomy and hypercapnia promote microglial reactivity in selected brain areas that regulate breathing. We used ionized calcium-binding-adapter molecule-1 (Iba1) immunolabeling to compare the density and morphology of microglia in the locus coeruleus (LC), the caudal medullary raphe, the caudal part of the nucleus of the tractus solitarius (cNTS), and the paraventricular nucleus of the hypothalamus (PVN). Tissue was obtained from SHAM (metaestrus) female rats or following ovariectomy. Rats were exposed to normocapnia or hypercapnia (5% CO2, 20 min). Ovariectomy and hypercapnia did not affect microglial density in any of the structures studied. Ovariectomy promoted a reactive phenotype in the cNTS and LC, as indicated by a larger morphological index. In these structures, hypercapnia had a relatively modest opposing effect; the medullary raphe or the PVN were not affected. We conclude that ovarian hormones attenuate microglial reactivity in CO2/H+ sensing structures. These data suggest that microglia may contribute to neurological diseases in which anomalies of respiratory control are associated with cyclic fluctuations of ovarian hormones or menopause.
Subject(s)
Brain Stem/drug effects , Carbon Dioxide/pharmacology , Microglia/pathology , Ovariectomy/adverse effects , Respiration , Animals , Brain Stem/pathology , Brain Stem/physiopathology , Carbon Dioxide/metabolism , Hypercapnia/physiopathology , Hypothalamus/drug effects , Hypothalamus/pathology , Hypothalamus/physiopathology , Microglia/drug effects , Neurons/drug effects , Neurons/pathology , Rats, Sprague-DawleyABSTRACT
Cocoa flavanols protect humans against vascular disease, as evidenced by improvements in peripheral endothelial function, likely through nitric oxide signalling. Emerging evidence also suggests that flavanol-rich diets protect against cognitive aging, but mechanisms remain elusive. In a randomized double-blind within-subject acute study in healthy young adults, we link these two lines of research by showing, for the first time, that flavanol intake leads to faster and greater brain oxygenation responses to hypercapnia, as well as higher performance only when cognitive demand is high. Individual difference analyses further show that participants who benefit from flavanols intake during hypercapnia are also those who do so in the cognitive challenge. These data support the hypothesis that similar vascular mechanisms underlie both the peripheral and cerebral effects of flavanols. They further show the importance of studies combining physiological and graded cognitive challenges in young adults to investigate the actions of dietary flavanols on brain function.
Subject(s)
Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cognition/drug effects , Flavonols/administration & dosage , Oxygen/metabolism , Adult , Cacao , Cerebral Cortex/blood supply , Cerebrovascular Circulation/drug effects , Dietary Supplements , Double-Blind Method , Healthy Volunteers , Humans , Hypercapnia/diet therapy , Hypercapnia/physiopathology , Hypercapnia/psychology , Male , Middle Aged , Oxygen Consumption/drug effects , Oxyhemoglobins/metabolism , Young AdultABSTRACT
Background: Despite the encouraging results of noninvasive ventilation (NIV) in chronic hypercapnic COPD patients, it is also evident that some patients do not tolerate NIV or do not benefit from it. We conducted a study in which COPD patients with stable, chronic hypercapnia were treated with NIV and nasal high-flow (NHF) to compare effectiveness. Methods: In a multi-centered, randomized, controlled, cross-over design, patients received 6 weeks of NHF ventilation followed by 6 weeks of NIV ventilation or vice-versa (TIBICO) between 2011 and 2016. COPD patients with stable daytime hypercapnia (pCO2≥50 mmHg) were recruited from 13 German centers. The primary endpoint was pCO2 changes from baseline blood gas, lung function, quality of life (QoL), the 6 min walking test, and duration of device use were secondary endpoints. Results: A total of 102 patients (mean±SD) age 65.3±9.3 years, 61% females, body mass index 23.1±4.8 kg/m2, 90% GOLD D, pCO2 56.5±5.4 mmHg were randomized. PCO2 levels decreased by 4.7% (n=94; full analysis set; 95% CI 1.8-7.5, P=0.002) using NHF and 7.1% (95% CI 4.1-10.1, P<0.001) from baseline using NIV (indistinguishable to intention-to-treat analysis). The difference of pCO2 changes between the two devices was -1.4 mmHg (95% CI -3.1-0.4, P=0.12). Both devices had positive impact on blood gases and respiratory scores (St. George's Respiratory Questionnaire, Severe Respiratory Insufficiency Questionnaire). Conclusions: NHF may constitute an alternative to NIV in COPD patients with stable chronic hypercapnia, eg, those not tolerating or rejecting NIV with respect to pCO2 reduction and improvement in QoL.
Subject(s)
Hypercapnia/therapy , Lung/physiopathology , Noninvasive Ventilation , Oxygen Inhalation Therapy , Pulmonary Disease, Chronic Obstructive/therapy , Administration, Intranasal , Aged , Cross-Over Studies , Germany , Humans , Hypercapnia/diagnosis , Hypercapnia/physiopathology , Middle Aged , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/physiopathology , Quality of Life , Recovery of Function , Time Factors , Treatment OutcomeABSTRACT
Increased nitric oxide (NO) bioavailability may improve exercise performance and vascular function. It remains unclear whether older adults who experience a decreased NO bioavailability may benefit from chronic NO precursor supplementation. This randomised, double-blind, trial aims to assess the effect of chronic NO precursor intake on vascular function and exercise performance in older adults (60-70 years old). Twenty-four healthy older adults (12 females) performed vascular function assessment and both local (knee extensions) and whole-body (incremental cycling) exercise tests to exhaustion before and after one month of daily intake of a placebo (PLA) or a nitrate-rich salad and citrulline (N+C, 520mg nitrate and 6g citrulline) drink. Arterial blood pressure (BP) and stiffness, post-ischemic, hypercapnic and hypoxic vascular responses were evaluated. Prefrontal cortex and quadriceps oxygenation was monitored by near-infrared spectroscopy. N+C supplementation reduced mean BP (-3.3mmHg; p=0.047) without altering other parameters of vascular function and oxygenation kinetics. N+C supplementation reduced heart rate and oxygen consumption during submaximal cycling and increased maximal power output by 5.2% (p<0.05), but had no effect on knee extension exercise performance. These results suggest that chronic NO precursor supplementation in healthy older individuals can reduce resting BP and increase cycling performance by improving cardiorespiratory responses.
Subject(s)
Athletic Performance/physiology , Blood Vessels/physiology , Citrulline/administration & dosage , Dietary Supplements , Nitrates/administration & dosage , Aged , Diagnostic Techniques, Cardiovascular , Double-Blind Method , Female , Hemodynamics , Humans , Hypercapnia/physiopathology , Hypoxia/physiopathology , Male , Middle AgedABSTRACT
The hypothalamus is a higher center of the autonomic nervous system and maintains essential body homeostasis including respiration. The paraventricular nucleus, perifornical area, dorsomedial hypothalamus, and lateral and posterior hypothalamus are the primary nuclei of the hypothalamus critically involved in respiratory control. These hypothalamic nuclei are interconnected with respiratory nuclei located in the midbrain, pons, medulla and spinal cord. We provide an extensive review of the role of the above hypothalamic nuclei in the maintenance of basal ventilation, and modulation of respiration in hypoxic and hypercapnic conditions, during dynamic exercise, in awake and sleep states, and under stress. Dysfunction of the hypothalamus causes abnormal breathing and hypoventilation. However, the cellular and molecular mechanisms how the hypothalamus integrates and modulates autonomic and respiratory functions remain to be elucidated.
Subject(s)
Exercise/physiology , Hypercapnia/physiopathology , Hypothalamus/physiology , Hypoxia/physiopathology , Nerve Net/physiology , Respiration , Respiratory Center/physiology , Stress, Psychological/physiopathology , Animals , Humans , Nerve Net/physiopathology , Respiratory Center/physiopathologyABSTRACT
The precise neural circuitry that mediates arousal during sleep apnea is not known. We previously found that glutamatergic neurons in the external lateral parabrachial nucleus (PBel) play a critical role in arousal to elevated CO2 or hypoxia. Because many of the PBel neurons that respond to CO2 express calcitonin gene-related peptide (CGRP), we hypothesized that CGRP may provide a molecular identifier of the CO2 arousal circuit. Here, we report that selective chemogenetic and optogenetic activation of PBelCGRP neurons caused wakefulness, whereas optogenetic inhibition of PBelCGRP neurons prevented arousal to CO2, but not to an acoustic tone or shaking. Optogenetic inhibition of PBelCGRP terminals identified a network of forebrain sites under the control of a PBelCGRP switch that is necessary to arouse animals from hypercapnia. Our findings define a novel cellular target for interventions that may prevent sleep fragmentation and the attendant cardiovascular and cognitive consequences seen in obstructive sleep apnea. VIDEO ABSTRACT.
Subject(s)
Arousal/genetics , Hypercapnia/genetics , Hypercapnia/physiopathology , Sleep/genetics , Acoustic Stimulation , Animals , Calcitonin Gene-Related Peptide/metabolism , Carbon Dioxide/metabolism , Carbon Dioxide/pharmacology , Electroencephalography , Electromyography , Mice , Mice, Inbred C57BL , Nerve Net/physiopathology , Neurons , Optogenetics , Patch-Clamp Techniques , Prosencephalon/physiopathology , Respiration , Sleep Apnea Syndromes/physiopathologyABSTRACT
Control of ventilation occurs at different levels of the respiratory system through a negative feedback system that allows precise regulation of levels of arterial carbon dioxide and oxygen. Mechanisms for ventilatory instability leading to sleep-disordered breathing include changes in the genesis of respiratory rhythm and chemoresponsiveness to hypoxia and hypercapnia, cerebrovascular reactivity, abnormal chest wall and airway reflexes, and sleep state oscillations. One can potentially stabilize breathing during sleep and treat sleep-disordered breathing by identifying one or more of these pathophysiological mechanisms. This review describes the current concepts in ventilatory control that pertain to breathing instability during wakefulness and sleep, delineates potential avenues for alternative therapies to stabilize breathing during sleep, and proposes recommendations for future research.
Subject(s)
Pulmonary Ventilation/physiology , Sleep Apnea Syndromes/prevention & control , Sleep Apnea Syndromes/physiopathology , Humans , Hypercapnia/physiopathology , Hypoxia/physiopathology , Wakefulness/physiologyABSTRACT
Chronic obstructive pulmonary disease can cause muscle fibre transformation due to chronic intermittent hypoxia-hypercapnia (CIHH). Studies have shown that high expression of Sox6 in muscle could suppress type-I fibres through downregulating the PPARß (peroxisome proliferator-activated receptor ß)/ERRγ (oestrogen-related receptor γ)/microRNA pathway. However, whether this pathway is involved in CIHH-induced muscle fibre transformation is unknown. Electrical stimulation (ES) is an effective approach to ameliorate muscle dysfunction. Here, we explored the effects of ES on CIHH-induced muscle fibre transformation and the microRNA/Sox6 pathway. After CIHH exposure, both the soleus (SOL) and gastrocnemius (GC) muscles showed decreased type-I fibres. The PPARß/ERRγ/mir-499&208b (PEM, for GC) and PPARß/mir-499&208b (PM, for SOL) signalling cascades were suppressed, followed by elevated Sox6 expression. Low frequency electrical stimulation (LFES) activated the PEM/PM pathway and enhanced type-I fibre numbers through suppressing Sox6 in SOL and GC. High frequency electrical stimulation (HFES) promoted type-I fibre expression through activating the PEM pathway in GC. Although PPARß expression and type-I fibres were suppressed in SOL after HFES, no significant change was found in mir-499&208b/Sox6 expression. These results suggest that the microRNA/Sox6 pathway is disturbed after CIHH. Both low and high frequency electrical stimulations induce muscle fibre transformation partly through regulating the microRNA/Sox6 pathway.
Subject(s)
Electric Stimulation Therapy/methods , Hypercapnia/therapy , Hypoxia/therapy , MicroRNAs/genetics , Muscle Fibers, Skeletal/pathology , SOXD Transcription Factors/metabolism , Animals , Disease Models, Animal , Humans , Hypercapnia/genetics , Hypercapnia/metabolism , Hypercapnia/physiopathology , Hypoxia/genetics , Hypoxia/metabolism , Hypoxia/physiopathology , Male , Muscle Fibers, Skeletal/metabolism , Muscle Fibers, Skeletal/physiology , PPAR-beta/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Estrogen/metabolism , Signal TransductionABSTRACT
KEY POINTS: Activation of central chemoreceptors by CO2 increases sympathetic nerve activity (SNA), arterial blood pressure (ABP) and breathing. These effects are exaggerated in spontaneously hypertensive rats (SHRs), resulting in an augmented CO2 chemoreflex that affects both breathing and ABP. The augmented CO2 chemoreflex and the high ABP are measureable in young SHRs (postnatal day 30-58) and become greater in adult SHRs. Blockade of orexin receptors can normalize the augmented CO2 chemoreflex and the high ABP in young SHRs and normalize the augmented CO2 chemoreflex and significantly lower the high ABP in adult SHRs. In the hypothalamus, SHRs have more orexin neurons, and a greater proportion of them increase their activity with CO2 . The orexin system is overactive in SHRs and contributes to the augmented CO2 chemoreflex and hypertension. Modulation of the orexin system may be beneficial in the treatment of neurogenic hypertension. ABSTRACT: Activation of central chemoreceptors by CO2 increases arterial blood pressure (ABP), sympathetic nerve activity and breathing. In spontaneously hypertensive rats (SHRs), high ABP is associated with enhanced sympathetic nerve activity and peripheral chemoreflexes. We hypothesized that an augmented CO2 chemoreflex and overactive orexin system are linked with high ABP in both young (postnatal day 30-58) and adult SHRs (4-6 months). Our main findings are as follows. (i) An augmented CO2 chemoreflex and higher ABP in SHRs are measureable at a young age and increase in adulthood. In wakefulness, the ventilatory response to normoxic hypercapnia is higher in young SHRs (mean ± SEM: 179 ± 11% increase) than in age-matched normotensive Wistar-Kyoto rats (114 ± 9% increase), but lower than in adult SHRs (226 ± 10% increase; P < 0.05). The resting ABP is higher in young SHRs (122 ± 5 mmHg) than in age-matched Wistar-Kyoto rats (99 ± 5 mmHg), but lower than in adult SHRs (152 ± 4 mmHg; P < 0.05). (ii) Spontaneously hypertensive rats have more orexin neurons and more CO2 -activated orexin neurons in the hypothalamus. (iii) Antagonism of orexin receptors with a dual orexin receptor antagonist, almorexant, normalizes the augmented CO2 chemoreflex in young and adult SHRs and the high ABP in young SHRs and significantly lowers ABP in adult SHRs. (iv) Attenuation of peripheral chemoreflexes by hyperoxia does not abolish the augmented CO2 chemoreflex (breathing and ABP) in SHRs, which indicates an important role for the central chemoreflex. We suggest that an overactive orexin system may play an important role in the augmented central CO2 chemoreflex and in the development of hypertension in SHRs.
Subject(s)
Carbon Dioxide/physiology , Hypertension/physiopathology , Orexins/physiology , Animals , Arterial Pressure , Hypercapnia/physiopathology , Hypothalamus/physiology , Male , Neurons/physiology , Pulmonary Ventilation , Rats, Inbred SHR , Rats, Inbred WKYABSTRACT
Yoga alters spontaneous respiratory regulation and reduces hypoxic and hypercapnic ventilatory responses. Since a lower ventilatory response is associated with an improved endurance capacity during whole-body exercise, we tested whether yogic subjects (YOGA) show an increased endurance capacity compared to matched non-yogic individuals (CON) with similar physical activity levels. Resting ventilation, the ventilatory response to hypercapnia, passive leg movement and exercise, as well as endurance performance were assessed. YOGA (n = 9), compared to CONTROL (n = 6), had a higher tidal volume at rest (0.7±0.2 vs. 0.5±0.1 l, p = 0.034) and a reduced ventilatory response to hypercapnia (33±15 vs. 47±15 l·min(-1), p = 0.048). A YOGA subgroup (n = 6) with maximal performance similar to CONTROL showed a blunted ventilatory response to passive cycling (11±2 vs. 14±2 l·min(-1), p = 0.039) and a tendency towards lower exercise ventilation (33±2 vs. 36±3 l·min(-1), p = 0.094) while cycling endurance (YOGA: 17.3±3.3; CON: 19.6±8.5 min, p = 0.276) did not differ. Thus, yoga practice was not associated with improved exercise capacity nor with significant changes in exercise ventilation despite a significantly different respiratory regulation at rest and in response to hypercapnia and passive leg movement.
Subject(s)
Physical Endurance/physiology , Respiration , Yoga , Adult , Female , Humans , Hypercapnia/physiopathology , Oxygen Consumption/physiology , Pulmonary Ventilation/physiology , Young AdultABSTRACT
AIM: To improve treatment results of patients with CAP using hypercapnic hypoxia as a part of an integrated therapy. MATERIALS AND METHODS: The study involved 37 men aged 20 to 50 years diagnosed with CAP. The subjects were randomly divided into 2 groups. The control group consisted of 17 (46%) patients who received only the basic therapy. The study group comprised 20 (54%) patients, who were treated with the basic therapy combined with a course of 10 treatment sessions of hypercapnic hypoxia using a respiratory device. Two study visits were organized before and after treatment, including medical history, physical examination, filling out questionnaires, DRE and TRUS of the prostate, uroflowmetry and laser flowmetry. RESULTS: In the both groups, the treatment resulted in reduction or relief of pain and dysuria that is a natural effect of the standard therapy. However, the study group showed significantly greater improvement. The findings of DRE and TRUS of the prostate in the study and control group did not differ significantly; the size of hypoechoic areas in the prostate decreased in the both groups. Laser flowmetry showed improvement in microcirculatory disturbances of the prostate, which were observed before treatment. CONCLUSION: Basic therapy has a clinical effect, but it is limited regarding hemodynamics and microcirculation of the prostate. These indices are lower than in the study group. Thus, the study findings show a high clinical efficacy of hypercapnic hypoxia as an add-on therapy in treating patients with CAP. There was a significant decrease in clinical manifestations of the disease which was caused by improving microcirculation. This resulted from improved blood circulation, increased blood perfusion and blood volume in the arterioles, increased blood inflow in the microcirculatory system, reduced tissue hypoxia and ischemia, improved blood flow regulation. The findings of the present study give us ground to recommend training using breathing simulator "Karbonik" in the combination therapy of patients with CAP, which significantly increases the treatment effectiveness.
Subject(s)
Hypercapnia , Hypoxia , Prostate , Prostatitis , Adult , Humans , Hypercapnia/complications , Hypercapnia/physiopathology , Hypoxia/complications , Hypoxia/physiopathology , Male , Middle Aged , Prostate/blood supply , Prostate/physiopathology , Prostatitis/etiology , Prostatitis/physiopathologyABSTRACT
Pulmonary arterial hypertension (PAH) is a disease of the small pulmonary arteries characterized by increased vascular resistance. Pulmonary vasoconstriction has been proven to play a pivotal role in PAH. We have previously hypothesized that Panax notoginseng saponins (PNS) might attenuate hypoxia-hypercapnia-induced pulmonary vasoconstriction. The specific objective of the present study was to investigate the role of notoginsenoside R1, a main ingredient of PNS, in this process and the possible underlying mechanism. The third order pulmonary rings from the Sprague-Dawley rats were treated with different concentrations of notoginsenoside R1 (8, 40, and 100 mg/L, respectively) both before and during the conditions of hypercapnia and hypoxia. Contractile force changes in the rings were detected and the optimal concentration (8 mg/L) was selected. Furthermore, an ERK inhibitor, U0126, was applied to the rings. In addition, pulmonary arterial smooth muscle cells (PASMCs) were cultured under hypoxic and hypercapnic conditions, and notoginsenoside R1 was administered to detect the changes induced by ERK1/2. The results revealed biphasic vasoconstriction in rings under hypoxic and hypercapnic conditions. It is hypothesized that the observed attenuation of vasoconstriction and the production of vasodilation could have been induced by notoginsenoside R1. This effect was found to be significantly reinforced by U0126 (p < 0.05 or p < 0.01). ERK expression in the PASMCs under hypoxic and hypercapnic conditions was significantly activated (p < 0.05 or p < 0.01) and the observed activation was attenuated by notoginsenoside R1 (p < 0.05 or p < 0.01). Our findings strongly support the significant role of notoginsenoside R1 in the inhibition of hypoxia-hypercapnia-induced vasoconstriction by the ERK pathway.
Subject(s)
Extracellular Signal-Regulated MAP Kinases/metabolism , Ginsenosides/pharmacology , Hypercapnia/physiopathology , Hypoxia/physiopathology , MAP Kinase Signaling System/physiology , Muscle, Smooth, Vascular/drug effects , Pulmonary Artery/drug effects , Vasoconstriction/drug effects , Animals , Cells, Cultured , Extracellular Signal-Regulated MAP Kinases/physiology , In Vitro Techniques , Male , Panax notoginseng , Rats, Sprague-DawleyABSTRACT
BACKGROUND: Patients with transient ischaemic attacks (TIAs) or minor disabling ischaemic stroke associated with an internal carotid artery (ICA) occlusion have a high risk of recurrent stroke in case of compromised cerebral blood flow. Recent studies showed that increased oxygen extraction fraction measured by positron emission tomography (PET) is still an independent predictor of subsequent stroke under current medical treatment, but PET facilities are not widely available. Transcranial Doppler (TCD) ultrasonography CO2 reactivity is a cheap and non-invasive alternative to measure haemodynamic compromise. The aim of our study was to investigate whether TCD CO2 reactivity is an independent predictor of recurrent ischaemic stroke in a large cohort of patients with symptomatic ICA occlusion in a time where rigorous control of vascular risk factors has been widely implemented in clinical practice. METHODS: Between July 1995 and December 2009, we included consecutive patients with TIAs or minor disabling ischaemic stroke (modified Rankin Scale ≤3) associated with ICA occlusion who were referred to the University Medical Centre Utrecht, The Netherlands. All patients were treated with antiplatelet therapy and received rigorous control of vascular risk factors, including statins, treatment for diabetes and hypertension and lifestyle advices. CO2 reactivity was measured with TCD within 3 months after presentation. We determined the predictive value of TCD CO2 reactivity for recurrent ischaemic stroke using Cox proportional hazard analysis. RESULTS: We included 201 patients with a median follow-up time of 7.1 years. Mean CO2 reactivity was 15% (±20 standard deviation). The annual rate for ipsilateral ischaemic stroke was 2.2% [95% confidence interval (CI) 1.4-3.2] and for any recurrent stroke 3.2% (95% CI 2.3-4.4). We did not find a significant relationship between CO2 reactivity and the risk of ipsilateral [hazard ratio (HR) for every increase in percentage point 1.01, 95% CI 0.99-1.02] or any recurrent ischaemic stroke (HR 1.01, 95% CI 0.998-1.02). Multivariable analysis showed a significant relationship with history of stroke (HR 4.0, 95% CI 1.8-9.0) for ipsilateral recurrent stroke, and age (HR for increase per year 1.05, 95% CI 1.01-1.09) and a history of stroke (HR 3.4, 95% CI 1.7-6.6) for any recurrent stroke. CONCLUSIONS: In patients with TIAs or non-disabling stroke associated with occlusion of the carotid artery, the long-term annual risk of stroke is generally low with careful control of vascular risk factors. Impaired CO2 reactivity measured within 3 months after presentation does not identify the subgroup of patients at high risk of recurrent ischaemic stroke.
Subject(s)
Brain Ischemia/epidemiology , Carbon Dioxide/blood , Carotid Artery Thrombosis/diagnostic imaging , Cerebrovascular Circulation , Ultrasonography, Doppler, Transcranial , Vasomotor System/physiopathology , Aged , Blood Flow Velocity , Brain Ischemia/etiology , Cardiovascular Diseases/mortality , Carotid Artery Thrombosis/complications , Female , Follow-Up Studies , Humans , Hypercapnia/blood , Hypercapnia/physiopathology , Male , Middle Aged , Oxygen , Partial Pressure , Platelet Aggregation Inhibitors/therapeutic use , Prognosis , Recurrence , Risk Assessment , Risk Factors , Treatment OutcomeABSTRACT
The relative efficiency of trainings with isolated hypoxia, hypercapnia and hypoxia in aggregate with hypercapnia in order to enhance the resistance of organism to the effect of an extreme hypoxia was studied. The combined effect of the hypoxia and hypercapnia was shown to influence more greatly in comparison with the effect of an isolated hypoxia. This effect was supported with an increase in the time of the loss position and the time of the animal's life under the condition of an extreme hypoxia. Also it is shown that the hypercapnia in a combination to a hypoxia makes dominating impact on formation of nonspecific resistance as the isolated hypercapnia enlarges indicators of nonspecific resistance, than the isolated hypoxia more effectively.
Subject(s)
Hypercapnia/physiopathology , Hypoxia/physiopathology , Animals , Case-Control Studies , Hyperbaric Oxygenation/methods , Hypoxia/therapy , Male , Physical Exertion , Rats , Rats, Wistar , Treatment OutcomeABSTRACT
In experiments on nonlinear male mice the ability of new derivatives of nitrogen-containing heterocyclic compounds to increase the physical working capacity in conditions of hyperthermia, hypothermia and acute normobaric hypoxia and hypercapnia has been investigated. It is established, that pyridine derivative IBHF-11 has more expressed positive action in the said conditions. It provided increase of the working capacity of animals at all kinds of extreme influence, and the value of positive action was comparable, and in conditions of acute normobaric hypoxia and hypercapnia exceeded those at the reference products bemitil and bromantan.
Subject(s)
Amantadine/analogs & derivatives , Antioxidants/pharmacology , Benzimidazoles/pharmacology , Fever/drug therapy , Hypercapnia/drug therapy , Hypothermia/drug therapy , Hypoxia/drug therapy , Physical Endurance/drug effects , Amantadine/pharmacology , Animals , Drug Evaluation, Preclinical , Fever/physiopathology , Hypercapnia/physiopathology , Hypothermia/physiopathology , Hypoxia/physiopathology , Male , MiceABSTRACT
It is unknown whether the respiratory muscles contribute to exercise-induced increases in plasma interleukin-6 (IL-6) concentration, if this is related to diaphragm fatigue, and whether inspiratory muscle training (IMT) attenuates the plasma IL-6 response to whole body exercise and/or a volitional mimic of the exercise hyperpnea. Twelve healthy males were divided equally into an IMT or placebo (PLA) group, and before and after a 6-wk intervention they undertook, on separate days, 1 h of 1) passive rest, 2) cycling exercise at estimated maximal lactate steady state power (EX), and 3) volitional hyperpnea at rest, which mimicked the breathing and respiratory muscle recruitment patterns achieved during EX (HYPEX). Plasma IL-6 concentration remained unchanged during passive rest. The plasma IL-6 response to EX was reduced following IMT (main effect of intervention, P = 0.039) but not PLA (P = 0.272). Plasma IL-6 concentration increased during HYPEX (main effect of time, P < 0.01) and was unchanged postintervention. There was no evidence of diaphragm fatigue (measured by phrenic nerve stimulation) following each trial. In conclusion, plasma IL-6 concentration is increased during EX and HYPEX and this occurred in the absence of diaphragm fatigue. Furthermore, IMT reduced the plasma IL-6 response to EX but not HYPEX. These findings suggest that the respiratory muscles contribute to exercise-induced increases in plasma IL-6 concentration in the absence of diaphragm fatigue and that IMT can reduce the magnitude of the response to exercise but not a volitional mimic of the exercise hyperpnea.
Subject(s)
Bicycling , Breathing Exercises , Diaphragm/metabolism , Exercise , Hypercapnia/blood , Inhalation , Interleukin-6/blood , Volition , Adult , Biomarkers/blood , Diaphragm/innervation , Diaphragm/physiopathology , Electric Stimulation , Humans , Hypercapnia/physiopathology , Lactic Acid/blood , Male , Muscle Fatigue , Perception , Phrenic Nerve/physiopathology , Pressure , Respiratory Rate , Time Factors , Young AdultABSTRACT
The mechanisms of arousal from apneas during sleep in patients suffering from obstructive sleep apnea are not well understood. However, we know that respiratory chemosensory pathways converge on the parabrachial nucleus (PB), which sends glutamatergic projections to a variety of forebrain structures critical to arousal, including the basal forebrain, lateral hypothalamus, midline thalamus, and cerebral cortex. We tested the role of glutamatergic signaling in this pathway by developing an animal model for repetitive CO2 arousals (RCAs) and investigating the effect of deleting the gene for the vesicular glutamate transporter 2 (Vglut2) from neurons in the PB. We used mice with lox P sequences flanking exon2 of the Vglut2 gene, in which adeno-associated viral vectors containing genes encoding Cre recombinase and green fluorescent protein were microinjected into the PB to permanently and selectively disrupt Vglut2 expression while labeling the affected neurons. We recorded sleep in these mice and then investigated the arousals during RCA. Vglut2 deletions that included the external lateral and lateral crescent subdivisions of the lateral PB more than doubled the latency to arousal and resulted in failure to arouse by 30 s in >30% of trials. By contrast, deletions that involved the medial PB subdivision had minimal effects on arousal during hypercapnia but instead increased non-rapid eye movement (NREM) sleep by â¼43% during the dark period, and increased delta power in the EEG during NREM sleep by â¼50%. Our results suggest that glutamatergic neurons in the lateral PB are necessary for arousals from sleep in response to CO2, while medial PB glutamatergic neurons play an important role in promoting spontaneous waking.
Subject(s)
Arousal , Brain Stem/physiology , Glutamic Acid/metabolism , Hypercapnia/physiopathology , Signal Transduction/physiology , Acoustic Stimulation , Analysis of Variance , Animals , Diphtheria Toxin/pharmacology , Electroencephalography , Electromyography , Eye Movements/physiology , Genetic Vectors/genetics , Green Fluorescent Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Plethysmography , Reaction Time/physiology , Sleep/physiology , Time Factors , Vesicular Glutamate Transport Protein 2/deficiency , Vesicular Glutamate Transport Protein 2/geneticsABSTRACT
To determine how the obstructive sleep apnea (OSA) patient's pathophysiological traits predict the success of the treatment aimed at stabilization or increase in respiratory motor outputs, we studied 26 newly diagnosed OSA patients [apnea-hypopnea index (AHI) 42 ± 5 events/h with 92% of apneas obstructive] who were treated with O2 supplementation, an isocapnic rebreathing system in which CO2 was added only during hyperpnea to prevent transient hypocapnia, and a continuous rebreathing system. We also measured each patient's controller gain below eupnea [change in minute volume/change in end-tidal Pco2 (ΔVe/ΔPetCO2)], CO2 reserve (eupnea-apnea threshold PetCO2), and plant gain (ΔPetCO2/ΔVe), as well as passive upper airway closing pressure (Pcrit). With isocapnic rebreathing, 14/26 reduced their AHI to 31 ± 6% of control (P < 0.01) (responder); 12/26 did not show significant change (nonresponder). The responders vs. nonresponders had a greater controller gain (6.5 ± 1.7 vs. 2.1 ± 0.2 l·min(-1)·mmHg(-1), P < 0.01) and a smaller CO2 reserve (1.9 ± 0.3 vs. 4.3 ± 0.4 mmHg, P < 0.01) with no differences in Pcrit (-0.1 ± 1.2 vs. 0.2 ± 0.9 cmH2O, P > 0.05). Hypercapnic rebreathing (+4.2 ± 1 mmHg PetCO2) reduced AHI to 15 ± 4% of control (P < 0.001) in 17/21 subjects with a wide range of CO2 reserve. Hyperoxia (SaO2 â¼95-98%) reduced AHI to 36 ± 11% of control in 7/19 OSA patients tested. We concluded that stabilizing central respiratory motor output via prevention of transient hypocapnia prevents most OSA in selected patients with a high chemosensitivity and a collapsible upper airway, whereas increasing respiratory motor output via moderate hypercapnia eliminates OSA in most patients with a wider range of chemosensitivity and CO2 reserve. Reducing chemosensitivity via hyperoxia had a limited and unpredictable effect on OSA.
Subject(s)
Breathing Exercises , Sleep Apnea, Obstructive/therapy , Adolescent , Adult , Aged , Arousal , Body Mass Index , Carbon Dioxide/metabolism , Data Interpretation, Statistical , Female , Humans , Hypercapnia/physiopathology , Hyperoxia/physiopathology , Male , Middle Aged , Polysomnography , Pulmonary Gas Exchange , Respiratory Mechanics/physiology , Sleep Apnea, Obstructive/classification , Sleep Apnea, Obstructive/rehabilitation , Young AdultABSTRACT
Black tea consumption has been shown to improve peripheral vascular function. Its effect on brain vasculature is unknown, though tea contains small amounts of caffeine, a psychoactive substance known to influence cerebral blood flow (CBF). We investigated the effects on CBF due to the intake of tea components in 20 healthy men in a double-blinded, randomized, placebo-controlled study. On separate days, subjects received a single dose of 184 mg caffeine (equivalent to one strong espresso coffee), 2,820 mg black tea solids containing 184 mg caffeine (equivalent to 6 cups of tea), 2,820 mg decaffeinated black tea solids, or placebo. The CBF and cerebrovascular reactivity (CVR) to hypercapnia were measured with arterial spin labeled magnetic resonance imaging (MRI) before and 2 hours after administration. We found a significant global reduction with caffeine (20%) and tea (21%) in gray matter CBF, with no effect of decaffeinated tea, suggesting that only caffeine influences CBF acutely. Voxelwise analysis revealed the effect of caffeine to be regionally specific. None of the interventions had an effect on CVR. Additional research is required to conclude on the physiologic relevance of these findings and the chronic effects of caffeine and tea intake on CBF.